体外诊断成分股数据 申万3级
851534.SI (39)
数据更新时间：2025-12-16
"-"表示无或者负数
| 序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值（亿元）
|
归母净利润同比增长(09-30)
|
归母净利润同比增长(06-30)
|
营业收入同比增长(09-30)
|
营业收入同比增长(06-30)
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 002932.SZ | 明德生物 | 2018-07-17 | — | — | 体外诊断 | 17.6 | 54.92 | 576.65 | 0.74 | 6.44% | 40.92 | -83.30% | -80.82% | 0.53% | -9.71% |
| 2 | 688389.SH | 普门科技 | 2023-09-25 | — | — | 体外诊断 | 13.07 | 16.21 | 22.31 | 2.67 | — | 56.00 | -36.66% | -29.27% | -10.96% | -14.08% |
| 3 | 002086.SZ | 东方海洋 | 2024-01-02 | — | — | 体外诊断 | 2.38 | — | — | 3.52 | — | 46.62 | -51.43% | -71.23% | -0.78% | 0.34% |
| 4 | 300439.SZ | 美康生物 | 2015-04-29 | — | — | 体外诊断 | 9.77 | 14.55 | 39.87 | 1.27 | 1.38% | 37.55 | -73.02% | -68.15% | -19.27% | -22.43% |
| 5 | 002030.SZ | 达安基因 | 2004-08-16 | — | — | 体外诊断 | 6.04 | — | — | 1.1 | — | 84.77 | 71.85% | 54.37% | -14.81% | -15.44% |
| 6 | 688253.SH | 英诺特 | 2023-09-25 | — | — | 体外诊断 | 31.25 | 17.34 | 32.08 | 2.11 | — | 42.81 | -46.37% | -39.36% | -36.56% | -34.35% |
| 7 | 300642.SZ | 透景生命 | 2017-04-28 | — | — | 体外诊断 | 18.2 | 85.67 | 185.87 | 2.01 | 0.82% | 29.59 | -76.33% | -58.41% | -19.73% | -26.25% |
| 8 | 600645.SH | 中源协和 | 1999-12-30 | — | — | 体外诊断 | 25.7 | 119.84 | 160.9 | 3.24 | — | 120.26 | -19.18% | -32.18% | -9.41% | -10.71% |
| 9 | 688606.SH | 奥泰生物 | 2023-09-25 | — | — | 体外诊断 | 62.46 | 16.37 | 16.8 | 1.3 | — | 49.52 | -3.91% | 6.57% | 2.44% | 8.41% |
| 10 | 688217.SH | 睿昂基因 | 2023-09-25 | — | — | 体外诊断 | 24.85 | — | — | 1.55 | — | 13.88 | -198.14% | -61.46% | -26.64% | -22.29% |
| 11 | 688068.SH | 热景生物 | 2023-09-25 | — | — | 体外诊断 | 172.38 | — | — | 5.45 | — | 159.81 | -168.12% | -93.24% | -19.80% | -18.04% |
| 12 | 300942.SZ | 易瑞生物 | 2021-02-23 | — | — | 体外诊断 | 9.36 | 221.51 | 121.35 | 4.48 | 0.18% | 37.91 | 362.49% | 250.02% | 17.45% | 5.44% |
| 13 | 002022.SZ | 科华生物 | 2004-07-28 | — | — | 体外诊断 | 5.98 | — | — | 0.99 | — | 30.76 | -90.38% | -154.37% | -11.77% | -12.65% |
| 14 | 688298.SH | 东方生物 | 2023-09-25 | — | — | 体外诊断 | 24.01 | — | — | 0.76 | — | 48.40 | 18.89% | -7.58% | 2.16% | -3.62% |
| 15 | 688399.SH | 硕世生物 | 2023-09-25 | — | — | 体外诊断 | 66.86 | — | — | 1.89 | — | 56.08 | -88.38% | -86.35% | -3.95% | -1.05% |
| 16 | 688575.SH | 亚辉龙 | 2023-09-25 | — | — | 体外诊断 | 14.01 | 26.55 | 55.86 | 2.95 | — | 80.05 | -72.36% | -84.82% | -7.69% | -15.79% |
| 17 | 688393.SH | 安必平 | 2023-09-25 | — | — | 体外诊断 | 21.76 | 95.63 | — | 1.66 | — | 20.36 | -136.34% | -176.38% | -28.29% | -30.11% |
| 18 | 688468.SH | 科美诊断 | 2023-09-25 | — | — | 体外诊断 | 7.26 | 22.92 | 51.55 | 2.07 | — | 29.12 | -62.94% | -68.24% | -24.13% | -27.03% |
| 19 | 688338.SH | 赛科希德 | 2023-09-25 | — | — | 体外诊断 | 25.33 | 23.79 | 28.63 | 1.62 | — | 26.89 | -22.83% | -23.47% | -13.62% | -12.62% |
| 20 | 688067.SH | 爱威科技 | 2023-09-25 | — | — | 体外诊断 | 23.73 | 70.65 | 59.88 | 3.13 | — | 16.14 | 16.35% | 21.16% | 11.63% | 12.70% |
| 21 | 688317.SH | 之江生物 | 2023-09-25 | — | — | 体外诊断 | 20.11 | — | — | 1.14 | — | 38.64 | -125.82% | -137.88% | -34.27% | -36.91% |
| 22 | 300463.SZ | 迈克生物 | 2015-06-04 | — | — | 体外诊断 | 11.26 | 53.69 | — | 1.08 | 0.93% | 68.09 | -86.81% | -83.12% | -17.44% | -15.94% |
| 23 | 688426.SH | 康为世纪 | 2024-07-31 | — | — | 体外诊断 | 24.47 | — | — | 1.98 | — | 27.53 | 20.37% | -11.70% | 42.01% | 29.74% |
| 24 | 688193.SH | 仁度生物 | 2023-09-25 | — | — | 体外诊断 | 44.48 | — | — | 1.95 | — | 17.82 | 50.15% | -52.94% | -8.79% | -6.27% |
| 25 | 300832.SZ | 新产业 | 2020-05-19 | — | — | 体外诊断 | 59.2 | 25.44 | 28.2 | 5.32 | 2.2% | 465.15 | -12.92% | -14.62% | 0.39% | -1.18% |
| 26 | 300685.SZ | 艾德生物 | 2017-08-09 | — | — | 体外诊断 | 20.34 | 31.25 | 27.45 | 4.07 | 1.47% | 79.64 | 15.50% | 31.41% | 2.08% | 6.69% |
| 27 | 300396.SZ | 迪瑞医疗 | 2014-09-17 | — | — | 体外诊断 | 12.77 | 24.54 | — | 1.84 | 2.04% | 34.82 | -145.31% | -117.13% | -60.12% | -60.07% |
| 28 | 300406.SZ | 九强生物 | 2014-11-06 | — | — | 体外诊断 | 13.07 | 14.39 | 17.75 | 2.07 | 6.85% | 76.63 | -27.03% | -30.01% | -18.24% | -18.67% |
| 29 | 603387.SH | 基蛋生物 | 2017-07-24 | — | — | 体外诊断 | 8.06 | 18.28 | 19.58 | 1.52 | 2.23% | 40.88 | -8.48% | -25.88% | -13.88% | -17.00% |
| 30 | 002432.SZ | 九安医疗 | 2022-08-01 | — | — | 体外诊断 | 41.7 | 11.62 | 10.26 | 0.87 | 0.44% | 193.87 | 16.11% | 52.91% | -48.89% | -43.35% |
| 31 | 300289.SZ | 利德曼 | 2012-02-23 | — | — | 体外诊断 | 6.91 | — | — | 2.27 | — | 37.59 | -765.83% | -800.43% | -10.49% | -14.80% |
| 32 | 603658.SH | 安图生物 | 2016-09-08 | — | — | 体外诊断 | 35.97 | 17.21 | 18.72 | 2.35 | 3.5% | 205.54 | -10.11% | -7.83% | -7.48% | -6.65% |
| 33 | 300482.SZ | 万孚生物 | 2015-07-07 | — | — | 体外诊断 | 19.72 | 16.44 | 35.58 | 1.71 | 2.09% | 92.31 | -69.32% | -46.82% | -22.52% | -20.92% |
| 34 | 688289.SH | 圣湘生物 | 2023-09-25 | — | — | 体外诊断 | 18.51 | 38.91 | 39.5 | 1.5 | — | 107.24 | -2.10% | 3.84% | 20.49% | 21.15% |
| 35 | 300639.SZ | 凯普生物 | 2017-04-19 | — | — | 体外诊断 | 5.43 | — | — | 0.91 | — | 35.10 | 51.25% | -16.46% | -20.38% | -22.96% |
| 36 | 600807.SH | 济高发展 | 2024-07-31 | — | — | 体外诊断 | 3.21 | — | — | 64.73 | — | 28.40 | -78.54% | -57.51% | -17.59% | -23.36% |
| 37 | 688656.SH | 浩欧博 | 2023-09-25 | — | — | 体外诊断 | 196.69 | 339.25 | 342.73 | 15.06 | — | 124.86 | -1.41% | -39.10% | -4.84% | -6.48% |
| 38 | 688767.SH | 博拓生物 | 2023-09-25 | — | — | 体外诊断 | 37.12 | 32.7 | 54.05 | 2.37 | — | 55.43 | -75.04% | -82.82% | -20.76% | -23.91% |
| 39 | 688075.SH | 安旭生物 | 2023-09-25 | — | — | 体外诊断 | 37.5 | 24.78 | 39.43 | 0.92 | — | 47.66 | -52.60% | -48.57% | -19.34% | -7.42% |
免责声明：数据相关栏目所收集数据，均来自第三方个人或企业公开数据以及国家统计网站公开发布数据，数据由计算机技术自动收集更新再由作者校验，作者将尽力校验，但不能保证数据的完全准确。 阅读本栏目的用户必须明白，图表所示结果或标示仅供学习参考使用，均不构成交易依据。任何据此进行交易等行为，而引致的任何损害后果，本站概不负责。
关注微信公众号
获取更多数据
获取更多数据
关闭 X